Literature DB >> 15040880

Algorithms for prostate-specific antigen recurrence after treatment of localized prostate cancer.

Michael W Kattan1, James Eastham.   

Abstract

Nomograms are devices that predict outcome probabilities for the individual patient. Herein we discuss their strengths and limitations, focusing on responses to several frequently asked questions about nomograms. We believe these tools are useful and necessary for patient counseling, follow-up scheduling, and clinical trial design and analysis.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 15040880     DOI： 10.3816/cgc.2003.n.003

Source DB:  PubMed          Journal:  Clin Prostate Cancer        ISSN： 1540-0352


  8 in total

Review 1.  [Diagnostics and treatment of prostate cancer after kidney transplantation].

Authors:  A Wicht; A Hamza; H Loertzer; M Dietl; H Heynemann; P Fornara
Journal:  Urologe A       Date:  2006-01       Impact factor: 0.639

2.  Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.

Authors:  Jack Cuzick; Gregory P Swanson; Gabrielle Fisher; Arthur R Brothman; Daniel M Berney; Julia E Reid; David Mesher; V O Speights; Elzbieta Stankiewicz; Christopher S Foster; Henrik Møller; Peter Scardino; Jorja D Warren; Jimmy Park; Adib Younus; Darl D Flake; Susanne Wagner; Alexander Gutin; Jerry S Lanchbury; Steven Stone
Journal:  Lancet Oncol       Date:  2011-03       Impact factor: 41.316

3.  Down-regulation of dual-specificity phosphatase 5 predicts poor prognosis of patients with prostate cancer.

Authors:  Chao Cai; Jin-Yan Chen; Zhao-Dong Han; Hui-Chan He; Jia-Hong Chen; Yan-Ru Chen; Sheng-Bang Yang; Yong-Ding Wu; Yan-Ru Zeng; Jun Zou; Yu-Xiang Liang; Qi-Shan Dai; Fu-Neng Jiang; Wei-De Zhong
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 4.  Cancer/testis antigens: novel tools for discerning aggressive and non-aggressive prostate cancer.

Authors:  Takumi Shiraishi; Robert H Getzenberg; Prakash Kulkarni
Journal:  Asian J Androl       Date:  2012-02-20       Impact factor: 3.285

5.  Interobserver variability in histologic evaluation of radical prostatectomy between central and local pathologists: findings of TAX 3501 multinational clinical trial.

Authors:  George J Netto; Mario Eisenberger; Jonathan I Epstein
Journal:  Urology       Date:  2010-12-13       Impact factor: 2.649

Review 6.  Multiparametric magnetic resonance imaging in prostate cancer: present and future.

Authors:  John Kurhanewicz; Daniel Vigneron; Peter Carroll; Fergus Coakley
Journal:  Curr Opin Urol       Date:  2008-01       Impact factor: 2.309

7.  Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501): important lessons for future trials.

Authors:  Michael T Schweizer; Peng Huang; Michael W Kattan; Adam S Kibel; Ronald de Wit; Cora N Sternberg; Jonathan I Epstein; Mario A Eisenberger
Journal:  Cancer       Date:  2013-08-13       Impact factor: 6.860

8.  Diseases and Molecular Diagnostics: A Step Closer to Precision Medicine.

Authors:  Shailendra Dwivedi; Purvi Purohit; Radhieka Misra; Puneet Pareek; Apul Goel; Sanjay Khattri; Kamlesh Kumar Pant; Sanjeev Misra; Praveen Sharma
Journal:  Indian J Clin Biochem       Date:  2017-08-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.